About: Olivier Caron

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Olivier Caron Goto Sponge NotDistinct Permalink

An Entity of Type : foaf:Person, within Data Space : data.idref.fr associated with source document(s)

Attributes	Values
type	Person
sameAs	Caron, Olivier (1974-.... ; médecin) Caron, Olivier (1974-.... ; médecin)
alternative label	Caron, Olivier Pierre Emmanuel
Life Event	http://www.idref.fr/077414527/birth
preferred label	Caron, Olivier (1974-.... ; médecin)
name	Olivier Caron
dbpedia-owl:citizenship	http://sws.geonames.org/3017382/
Language	http://lexvo.org/id/iso639-3/fra
Given name	Olivier
familyName	Caron
has biographical i...tion (Deprecated)	Médecin, spécialiste d'onco-génétique. En poste à l'Institut de cancérologie Gustave Roussy, à Villejuif (en 2020)
gender	male
ORCID iD	0000-0001-8934-2071
is sameAs of	Caron, Olivier (1974-.... ; médecin) Caron, Olivier (1974-.... ; médecin) Caron, Olivier (1974-.... ; médecin)
is Thesis advisor of	http://www.sudoc.fr/278454666/id
is Author of	http://www.sudoc.fr/077414446/id Etude Genesis : deux ans d'inclusion ! Novel FH mutations in families with hereditary leiomyomatosis renal cell cancer (HLRCC) and in patients with isolated type 2 papillary renal cell carcinoma Abstract P6-08-12: Feasibility of a nation-wide family-based study to assess cancer risks in families with a predicted pathogenic variant identified through hereditary breast and ovary multi-gene panel testing: The TUMOSPEC study Etude Genesis : trois ans d'inclusion en France Clinical relevance of 8q23, 15q13 and 18q21 SNP genotyping to evaluate colorectal cancer risk National recommendations of the French Genetics and Cancer Group - Unicancer on the modalities of multi-genes panel analyses in hereditary predispositions to tumors of the digestive tract Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutation Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1/2 carrier cohort (GENEPSO). Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort Breast Cancer Risk Associated with Estrogen Exposure and Truncating Mutation Location in BRCA1/2 Carriers Germline Mutations of Inhibins in Early-Onset Ovarian Epithelial Tumors Gene‐ and pathway‐level analyses of iCOGS variants highlight novel signaling pathways underlying familial breast cancer susceptibility Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. Which factors predict proposal and uptake of psychological counselling after BRCA1/2 test result disclosure? TUMOSPEC: A Nation-Wide Study of Hereditary Breast and Ovarian Cancer Families with a Predicted Pathogenic Variant Identified through Multigene Panel Testing Efficacy of anthracycline/taxane-based neo-adjuvant chemotherapy on triple-negative breast cancer in BRCA1 / BRCA2 mutation carriers Evaluation of Lynch syndrome modifier genes in 748 MMR mutation carriers A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma. Variation in breast cancer risk with mutation position smoking alcohol and chest X-ray history in the French National BRCA1/2 carrier cohort (GENEPSO) Germline CDKN2A/P16INK4A mutations contribute to genetic determinism of sarcoma GENESIS: a French national resource to study the missing heritability of breast cancer Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers Cancer risk management strategies and perceptions of unaffected women five years after predictive genetic testing for BRCA1/2 mutations Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing Germline copy number variation of genes involved in chromatin remodelling in families suggestive of Li-Fraumeni syndrome with brain tumours Targeted Sequencing of the Mitochondrial Genome of Women at High Risk of Breast Cancer without Detectable Mutations in BRCA1/2 Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers. [MUTYH-associated polyposis: Review and update of the French recommendations established in 2012 under the auspices of the National Cancer Institute (INCa)]. Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach Mutation screening of MIR146A/B and BRCA1/2 3′-UTRs in the GENESIS study Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers.
is primary topic of	http://www.idref.fr/077414527
is Opponent of	http://www.sudoc.fr/250431866/id

Faceted Search & Find service v1.13.91 as of Aug 16 2018

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software